Highly Efficient Photodynamic Therapy with Mitochondria‐Targeting Aggregation‐Induced Emission Photosensitizer for Retinoblastoma

L Zhou, L Chen, S Chen, Z Pu, M Gu… - Advanced Healthcare …, 2023 - Wiley Online Library
Retinoblastoma (RB) is an aggressive eye cancer in infancy and childhood, lethal by
metastasis if left untreated. Currently, the survival rate and the chance of saving vision …

Intravenous chemotherapy for retinoblastoma in the era of intravitreal chemotherapy: a systematic review

V Raval, RC Bowen, H Soto, A Singh - Ocular Oncology and Pathology, 2021 - karger.com
Purpose: The published data on ocular survival following intravenous chemotherapy of
retinoblastoma (RB) seems to be skewed by evolving practice patterns induced by use of …

Retinoblastoma

N Bornfeld, D Lohmann, NE Bechrakis, E Biewald - Der Ophthalmologe, 2020 - Springer
Retinoblastome stellen 6% aller malignen Tumoren bei Kindern unter einem Alter von 5
Jahren dar, die unbehandelt zu Erblindung der betroffenen Augen und Tod durch …

Controversies in the management of choroidal invasion in retinoblastoma

PR Pendri, G Chantada - International Ophthalmology Clinics, 2022 - journals.lww.com
Retinoblastoma is the most common childhood ocular cancer with a worldwide incidence of
around 9000 new cases each year. In highincome, medically advanced countries the …

Anemia and bone marrow suppression after intra-arterial chemotherapy in children with retinoblastoma: A retrospective analysis

C Zeng, M Han, J Fan, X He, R Jia, L Li, X Wen… - Frontiers in …, 2022 - frontiersin.org
Background Retinoblastoma (Rb) is a common ocular malignant tumor in children. Intra-
arterial chemotherapy (IAC) has been widely used in children with Rb and has achieved an …

[PDF][PDF] Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment

G Lavasidis, K Papaioannou, N Anagnostou… - Ocular Oncology and …, 2024 - karger.com
Background: Retinoblastoma, although rare, is one of the most common intraocular
malignancies worldwide. Its prognosis has improved significantly in the past few decades …

Intraarterial chemotherapy for retinoblastoma–initial experiences of a German reference centre

T Kiefer, S Schlüter, NE Bechrakis… - Klinische …, 2021 - thieme-connect.com
Hintergrund Das Retinoblastom, als häufigste intraokulare Tumorentität, bedarf einer
interdisziplinären und individuellen Therapie. Die intraarterielle Chemotherapie (IAC) …

Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma

E Chang, Y Zhou, D Musch, A Edmonds… - Graefe's Archive for …, 2023 - Springer
Purpose The goal of this study was to compare the efficacy of intraarterial chemotherapy
(IAC) for retinoblastoma delivered via the ophthalmic artery (OA) division of the internal …

Islet co-expression of CD133 and ABCB5 in human retinoblastoma specimens

M Zschoche, S Skosyrski, N Babst… - Klinische …, 2023 - thieme-connect.com
Background The role of CD133 und ABCB5 is discussed in treatment resistance in several
types of cancer. The objective of this study was to evaluate whether CD133+/ABCB5+ …

Морфогенез ретинобластомы при локальном введении цитостатиков

СВ Саакян, ИП Хорошилова-Маслова… - …, 2021 - ophthalmojournal.com
Морфогенез ретинобластомы при локальном введении цитостатиков Page 1
Офтальмология/Ophthalmology in Russia СВСаакян, ИПХорошилова-Маслова, ССТадевосян …